385 related articles for article (PubMed ID: 25546326)
1. Upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim JH; Park HS
Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
[TBL] [Abstract][Full Text] [Related]
2. An update on the pathogenesis of the upper airways in aspirin-exacerbated respiratory disease.
Choi JH; Kim MA; Park HS
Curr Opin Allergy Clin Immunol; 2014 Feb; 14(1):1-6. PubMed ID: 24300420
[TBL] [Abstract][Full Text] [Related]
3. The role of aspirin desensitization followed by oral aspirin therapy in managing patients with aspirin-exacerbated respiratory disease: A Work Group Report from the Rhinitis, Rhinosinusitis and Ocular Allergy Committee of the American Academy of Allergy, Asthma & Immunology.
Stevens WW; Jerschow E; Baptist AP; Borish L; Bosso JV; Buchheit KM; Cahill KN; Campo P; Cho SH; Keswani A; Levy JM; Nanda A; Laidlaw TM; White AA
J Allergy Clin Immunol; 2021 Mar; 147(3):827-844. PubMed ID: 33307116
[TBL] [Abstract][Full Text] [Related]
4. [ASA-intolerance syndrome and persistent rhinosinusitis : Differential diagnosis and treatment].
Kirsche H; Klimek L
HNO; 2015 May; 63(5):357-63. PubMed ID: 25929893
[TBL] [Abstract][Full Text] [Related]
5. Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease.
Steinke JW; Liu L; Huyett P; Negri J; Payne SC; Borish L
J Allergy Clin Immunol; 2013 Oct; 132(4):856-65.e1-3. PubMed ID: 23806637
[TBL] [Abstract][Full Text] [Related]
6. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
Stevens WW; Ocampo CJ; Berdnikovs S; Sakashita M; Mahdavinia M; Suh L; Takabayashi T; Norton JE; Hulse KE; Conley DB; Chandra RK; Tan BK; Peters AT; Grammer LC; Kato A; Harris KE; Carter RG; Fujieda S; Kern RC; Schleimer RP
Am J Respir Crit Care Med; 2015 Sep; 192(6):682-94. PubMed ID: 26067893
[TBL] [Abstract][Full Text] [Related]
7. The time course of nasal cytokine secretion in patients with aspirin-exacerbated respiratory disease (AERD) undergoing aspirin desensitization: preliminary data.
San Nicoló M; Högerle C; Gellrich D; Eder K; Pfrogner E; Gröger M
Eur Arch Otorhinolaryngol; 2020 Feb; 277(2):445-452. PubMed ID: 31655881
[TBL] [Abstract][Full Text] [Related]
8. Aspirin exacerbated respiratory disease: Current topics and trends.
Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
[TBL] [Abstract][Full Text] [Related]
9. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
Simon RA; Dazy KM; Waldram JD
Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
[TBL] [Abstract][Full Text] [Related]
10. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
Ledford DK; Wenzel SE; Lockey RF
J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
[TBL] [Abstract][Full Text] [Related]
11. Role of aspirin desensitization in the management of chronic rhinosinusitis.
Rizk H
Curr Opin Otolaryngol Head Neck Surg; 2011 Jun; 19(3):210-7. PubMed ID: 21372715
[TBL] [Abstract][Full Text] [Related]
12. Aspirin desensitization: useful treatment for chronic rhinosinusitis with nasal polyps (CRSwNP) in aspirin-exacerbated respiratory disease (AERD)?
Klimek L; Dollner R; Pfaar O; Mullol J
Curr Allergy Asthma Rep; 2014 Jun; 14(6):441. PubMed ID: 24682773
[TBL] [Abstract][Full Text] [Related]
13. Current complications and treatment of aspirin-exacerbated respiratory disease.
Cook KA; Stevenson DD
Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: A meta-analysis of the literature.
Rajan JP; Wineinger NE; Stevenson DD; White AA
J Allergy Clin Immunol; 2015 Mar; 135(3):676-81.e1. PubMed ID: 25282015
[TBL] [Abstract][Full Text] [Related]
15. Aspirin desensitization in patients with aspirin-induced and aspirin-tolerant asthma: a double-blind study.
Świerczyńska-Krępa M; Sanak M; Bochenek G; Stręk P; Ćmiel A; Gielicz A; Plutecka H; Szczeklik A; Niżankowska-Mogilnicka E
J Allergy Clin Immunol; 2014 Oct; 134(4):883-90. PubMed ID: 24767875
[TBL] [Abstract][Full Text] [Related]
16. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes.
Laidlaw TM; Kidder MS; Bhattacharyya N; Xing W; Shen S; Milne GL; Castells MC; Chhay H; Boyce JA
Blood; 2012 Apr; 119(16):3790-8. PubMed ID: 22262771
[TBL] [Abstract][Full Text] [Related]
17. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
[TBL] [Abstract][Full Text] [Related]
18. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
O'Brien EK; Jerschow E; Divekar RD
Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
[TBL] [Abstract][Full Text] [Related]
19. Chronic Rhinosinusitis.
Trikha A; Kingdom T
J Allergy Clin Immunol Pract; 2015; 3(5):821-2; quiz 823. PubMed ID: 26362554
[No Abstract] [Full Text] [Related]
20. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
